Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
The Journal of Antimicrobial Chemotherapy
|
March 24, 2026
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions
Sanne van den Berg, Marie Attwood, Pippa Griffin, et al.
Antimicrobial Agents and Chemotherapy
|
August 10, 2016
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients
John S Bradley, Jon Armstrong, Antonio Arrieta, et al.
The Journal of Antimicrobial Chemotherapy
|
February 16, 2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance
Christopher A Darlow, Nicola Farrington, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy
|
September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings
Christopher A Darlow, Laura McEntee, Adam Johnson, et al.
Antimicrobial Agents and Chemotherapy
|
October 20, 2020
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia
Shampa Das, Richard Fitzgerald, Asad Ullah, et al.
The Journal of Antimicrobial Chemotherapy
|
October 16, 2024
Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA
Sonia Luque Pardos, William Hope, Antigone Kotsaki, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance
Christopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Nature Communications
|
September 18, 2025
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo
Vincent Gerusz, Pierre Regenass, Quentin Rousseau, et al.
Nature Communications
|
September 18, 2024
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections
Shahul Hameed P, Harish Kotakonda, Sreevalli Sharma, et al.
The Lancet. Infectious Diseases
|
October 3, 2024
Estimates of the burden of human rabies deaths and animal bites in India, 2022-23: a community-based cross-sectional survey and probability decision-tree modelling study
Jeromie Wesley Vivian Thangaraj, Navaneeth S Krishna, Shanmugasundaram Devika, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
The Journal of Antimicrobial Chemotherapy
|
March 24, 2026
The magnitude of the pharmacodynamic index for NOSO-502: pathogen clearance, emergence of resistance and human dose predictions
Sanne van den Berg, Marie Attwood, Pippa Griffin, et al.
Antimicrobial Agents and Chemotherapy
|
August 10, 2016
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients
John S Bradley, Jon Armstrong, Antonio Arrieta, et al.
The Journal of Antimicrobial Chemotherapy
|
February 16, 2022
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance
Christopher A Darlow, Nicola Farrington, Adam Johnson, et al.
The Journal of Antimicrobial Chemotherapy
|
September 30, 2022
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings
Christopher A Darlow, Laura McEntee, Adam Johnson, et al.
Antimicrobial Agents and Chemotherapy
|
October 20, 2020
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia
Shampa Das, Richard Fitzgerald, Asad Ullah, et al.
The Journal of Antimicrobial Chemotherapy
|
October 16, 2024
Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA
Sonia Luque Pardos, William Hope, Antigone Kotsaki, et al.
Antimicrobial Agents and Chemotherapy
|
May 11, 2021
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance
Christopher A Darlow, Fernando Docobo-Perez, Nicola Farrington, et al.
Nature Communications
|
September 18, 2025
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant Neisseria gonorrhoeae infection in vivo
Vincent Gerusz, Pierre Regenass, Quentin Rousseau, et al.
Nature Communications
|
September 18, 2024
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections
Shahul Hameed P, Harish Kotakonda, Sreevalli Sharma, et al.
The Lancet. Infectious Diseases
|
October 3, 2024
Estimates of the burden of human rabies deaths and animal bites in India, 2022-23: a community-based cross-sectional survey and probability decision-tree modelling study
Jeromie Wesley Vivian Thangaraj, Navaneeth S Krishna, Shanmugasundaram Devika, et al.
Page
of 6